# Gut Microbiota Transplantation in Systemic Sclerosis

> **NCT03444220** · PHASE1,PHASE2 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 10 (actual)

## Conditions studied

- Scleroderma, Systemic

## Interventions

- **BIOLOGICAL:** Anaerobically Cultivated Human Intestinal Microbiota
- **BIOLOGICAL:** Anaerobically Cultivated medium

## Key facts

- **NCT ID:** NCT03444220
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-18
- **Primary completion:** 2018-05-18
- **Final completion:** 2018-10-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03444220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03444220, "Gut Microbiota Transplantation in Systemic Sclerosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03444220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*